R&D Educating on the rewards of a career in life sciences A business is only as successful as its people - and the life sciences sector is no different.
Partner Content Partner Content Career opportunities for graduates in the pharmaceutical ind... Career opportunities for graduates in healthcare
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
